Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04628078

LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The study aims at comparing, in a large cohort of consecutive clinically indicated left atrial appendage closure, clinical and imaging outcomes between different subpopulations.

Detailed description

Percutaneous left atrial appendage closure (LAAC) has established itself in clinical practice as a safe and efficient therapeutic option for atrial fibrillation patients with a relative/absolute contraindication to oral anticoagulation. The purpose of this observational study is to prospectively collect procedural and follow-up data of all patients submitted to a clinically indicate LAAC in order to assess the impact of patient characteristics, procedural technique (imaging used to guide/plan procedure, device implanted, post-procedural drug regimens, etc.) on procedural safety and efficacy. The endpoints will be assessed by means of clinical follow-up at 1-3-5 years after LAAC and imaging exams (TEE at1-3 months, CCTA at 1-13months).

Conditions

Interventions

TypeNameDescription
OTHERUse of echocardiography guidance for LAACSince August 2015, the echocardiography is routinely used by majority of operators to guide LAAC

Timeline

Start date
2015-08-12
Primary completion
2023-06-01
Completion
2027-06-01
First posted
2020-11-13
Last updated
2023-02-22

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04628078. Inclusion in this directory is not an endorsement.